We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRTX
2051
TPG RE Finance Trust
TRTX
$606M
| $926K | ﹤0.01% |
50,640
+16,381
| +48% | +$321K |
|
2052
Motorcar Parts of America
MPAA
$257M
| $924K | ﹤0.01% |
55,530
+9,580
| +21% | +$182K |
|
|
THR
2053
DELISTED
Thermon Group Holdings
THR
| $924K | ﹤0.01% |
45,554
+14,760
| +48% | +$333K |
|
|
VRTV
2054
DELISTED
VERITIV CORPORATION
VRTV
| $922K | ﹤0.01% |
36,931
+7,614
| +26% | +$231K |
|
|
REN
2055
DELISTED
Resolute Energy Corporaton
REN
| $920K | ﹤0.01% |
31,738
+9,488
| +43% | +$300K |
|
|
HEES
2056
DELISTED
H&E Equipment Services
HEES
| $919K | ﹤0.01% |
45,022
+13,450
| +43% | +$330K |
|
|
BFX
2057
DELISTED
BowFlex Inc.
BFX
| $919K | ﹤0.01% |
84,294
+13,704
| +19% | +$171K |
|
2058
Community Trust Bancorp
CTBI
$1.42B
| $917K | ﹤0.01% |
23,150
+6,541
| +39% | +$287K |
|
2059
Mesa Laboratories
MLAB
$565M
| $915K | ﹤0.01% |
4,391
+1,476
| +51% | +$288K |
|
2060
TherapeuticsMD
TXMD
$24.2M
| $915K | ﹤0.01% |
4,803
+1,633
| +52% | +$398K |
|
|
PENG
2061
Penguin Solutions Inc
PENG
$2.88B
| $912K | ﹤0.01% |
61,384
+44,592
| +266% | +$675K |
|
|
IMGN
2062
DELISTED
Immunogen Inc
IMGN
| $906K | ﹤0.01% |
188,828
+62,794
| +50% | +$381K |
|
|
HUD
2063
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $901K | ﹤0.01% |
52,528
+16,816
| +47% | +$331K |
|
2064
CytomX Therapeutics
CTMX
$734M
| $893K | ﹤0.01% |
59,143
+21,402
| +57% | +$318K |
|
2065
German American Bancorp
GABC
$1.91B
| $892K | ﹤0.01% |
32,103
+9,936
| +45% | +$309K |
|
2066
Herc Holdings
HRI
$5.62B
| $892K | ﹤0.01% |
34,320
+10,814
| +46% | +$377K |
|
2067
Cerus
CERS
$468M
| $891K | ﹤0.01% |
175,711
+57,373
| +48% | +$333K |
|
2068
Liberty Latin America Class A
LILA
$1.75B
| $890K | ﹤0.01% |
95,999
+29,406
| +44% | +$340K |
|
|
APTS
2069
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $890K | ﹤0.01% |
63,275
+18,233
| +40% | +$285K |
|
|
TPC
2070
Tutor Perini Cor
TPC
$5.04B
| $880K | ﹤0.01% |
55,077
+16,078
| +41% | +$280K |
|
2071
Karyopharm Therapeutics
KPTI
$44.2M
| $879K | ﹤0.01% |
6,255
+3,411
| +120% | +$575K |
|
2072
iShares Russell Mid-Cap ETF
IWR
$56.7B
| $877K | ﹤0.01% |
18,863
-1,633
| -8% | -$82.4K |
|
2073
Spok Holdings
SPOK
$236M
| $875K | ﹤0.01% |
65,994
+7,992
| +14% | +$115K |
|
|
INFN
2074
DELISTED
Infinera Corporation Common Stock
INFN
| $874K | ﹤0.01% |
218,956
+64,349
| +42% | +$323K |
|
2075
Cushman & Wakefield Ltd
CWK
$3.2B
| $873K | ﹤0.01% |
60,325
+23,716
| +65% | +$396K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.